Short-chain fatty acids and their corresponding acyl-CoAs sit at the crossroads of metabolic pathways and play important roles in diverse cellular processes. They are also precursors for protein post-translational lysine acylation modifications. A noteworthy example is the newly identified lysine 2-hydroxyisobutyrylation (K hib ) that is derived from 2-hydroxyisobutyrate and 2-hydroxyisobutyryl-CoA. Histone K hib has been shown to be associated with active gene expression in spermatogenic cells. However, the key elements that regulate this post-translational lysine acylation pathway remain unknown. This has hindered characterization of the mechanisms by which this modification exerts its biological functions. Here we show that Esa1p in budding yeast and its homologue Tip60 in human could add K hib to substrate proteins both in vitro and in vivo. In addition, we have identified HDAC2 and HDAC3 as the major enzymes to remove K hib . Moreover, we report the first global profiling of K hib proteome in mammalian cells, identifying 6 548 K hib sites on 1 725 substrate proteins. Our study has thus discovered both the "writers" and "erasers" for histone K hib marks, and major K hib protein substrates. These results not only illustrate the landscape of this new lysine acylation pathway, but also open new avenues for studying diverse functions of cellular metabolites associated with this pathway.
Introduction
About 17 000 cellular metabolites are now annotated in the Kyoto Encyclopedia of Genes and Genomes (KEGG) database [1] . Previous studies demonstrated a few major mechanisms by which cellular metabolites exert their functions, such as reversible binding to a protein to activate or inhibit its function, and serving as a precursor for protein post-translational modifications (PTMs) [2] [3] [4] . Nevertheless, the scope and broad functions of most cellular metabolites remain unknown, representing one of major black boxes in modern biology [5] . Short-chain fatty acids are a family of metabolites that are generated by either metabolism of host mammalian cells or microbial fermentation in the gut [6] . Emerging evidence suggests that the microbial-derived metabolites can be either harmful or beneficial to human health [7, 8] . They have broad functions in signaling, host metabolism and immunity [9] . Despite much progress, the molecular mechanisms through which these molecules exert their function remain elusive. It was recently shown that short-chain fatty acids could serve as precursors for synthesis of their corresponding acyl-CoAs that in turn regulate histone modifications and gene expression [10] . This result leads to an intriguing hypothesis that metabolites from microbial fermentation can regulate epigenetic programs and control gene expression [11] .
2-Hydroxyisobutyrate, a cellular short-chain fatty acid, has been detected at high levels in the urine of obese people and is associated with the presence of some gut microbiota [12, 13] . The dynamics of symbiotic gut microbiota-associated metabolites, including 2-hydroxyisobutyrate, have been associated with diverse host metabolic phenotypes [13, 14] . Remarkably, 2-hydroxyisobutyrate is a precursor for the synthesis of 2-hydroxyisobutyryl-CoA and moreover, lysine 2-hydroxyisobutyrylation (K hib ), a new type of histone PTM [15] . This histone mark poses unique features that differ from the widely studied histone lysine acetylation (K ac ) and methylation (K me ) marks. It has a unique chemical structure, specific genomic distributions and exhibits varied dynamics among diverse model systems. ChIP-seq, gene expression analysis and immunodetection have indicated that in male germ cells H4K8 hib is associated with regions of active gene transcription, in both meiotic and post-meiotic cells. These lines of evidence suggest that K hib is mechanistically and functionally different from histone K ac and K me [15] . Importantly, we have identified a unique regulatory function of two cellular metabolites, 2-hydroxyisobutyrate and 2-hydroxyisobutyryl-CoA. Nevertheless, the key elements regulating this PTM pathway remain unknown, hindering functional studies of this modification in diverse biological systems and disease settings.
The history of PTM biology clearly shows that exploration of crucial regulatory proteins for a PTM pathway is key for studying its biology. In this respect, K ac provides an excellent example. K ac was originally discovered in core histones in the 1960s, findings that led to diverse correlative studies between histone K ac and chromatin structure and transcriptional activity [16, 17] . The identification of histone acetyltransferases was a turning point for K ac biology [18, 19] . Demonstration of the involvement of K ac in the regulation of p53 function inspired the research community to investigate the regulatory roles of K ac in transcription factors [20] . The identification of K ac substrates in cytosolic and mitochondrial proteins using proteomic approaches stimulated studies on the non-nuclear functions of this interesting PTM [21] [22] [23] [24] . Likewise, discovery of the building blocks for the K hib pathway will undoubtedly lay a concrete foundation for studying its diverse cellular functions.
In this study, by screening a yeast knock-out (YKO) library and through mutational studies, we found that the Esa1-containing Saccharomyces cerevisiae piccolo NuA4 (picNuA4) histone acetyltransferase complex has K hib transferase activity. Esa1p's human homolog Tip60, a well-known MYST family acetyltransferase member [25] , is also identified as a "writer" able to catalyze K hib in mammalian cells both in vitro and in vivo. In addition, we demonstrated that histone deacetylases2 (HDAC2) and HDAC3 in mammalian cells can both serve as "erasers" to remove K hib in vitro and in vivo. Moreover, we report the first global identification of K hib substrates in human cells. Our screen identified 6 548 unique K hib sites across 1 725 proteins in HeLa cells. Analysis of the substrate proteins reveals that K hib is closely associated with the processes of transcription, translation, protein degradation and energy metabolism. Together, our study reveals key building blocks of the K hib pathway, and therefore offers a rich source for studying the role of K hib in diverse cellular process and disease development.
Results

Esa1p in yeast catalyzes the K hib modification in vivo and in vitro
Identification of the regulatory enzymes of histone marks is instrumental in studying their functions. Previous studies suggested that p300, a member of lysine acetyltransferases (KATs), can have enzymatic activity not only for lysine acetylation but also for lysine propionylation, butyrylation and crotonylation [10, 26] . We therefore hypothesized that some KATs may also have activity toward K hib . To test this hypothesis, we took advantage of the haploid YKO collection and performed western blot analysis in each mutant strain in which a non-essential KAT was deleted. We found, unfortunately, that none of these enzymes was required for maintaining the H4K8 hib level ( Figure 1A) .
In addition to these non-essential KATs, the yeast genome encodes another KAT, Esa1p, the catalytic subunit of the nucleosome acetyltransferase of the H4 (NuA4) complex, which is required for cell viability [27] . Esa1p associates with Yng2p, Eaf6p and Epl1p to form the core machinery termed picNuA4, which is joined by Eaf1p and other components to form the large complex [28] .
We first tested if Esa1p could bind 2-hydroxyisobutyryl-CoA using structural modeling. Recently, we solved the crystal structure of the NuA4 core complex, which revealed a space-sequence double recognition mechanism for targeting the N-terminal tail of histone H4 [29] .
When we examined the structure of the catalytic pocket of Esa1p bound to acetyl-CoA (PDB 5J9W), we found that the catalytic pocket of Esa1p is large enough to accommodate other alkylated-CoAs with bigger acyl tails ( Figure 1B ). To test if 2-hydroxyisobutyryl-CoA would fit into the catalytic pocket of Esa1p, we modeled an Esa1p/2-hydroxyisobutyryl-CoA structure based on the structure of acetyl-CoA-bound Esa1p (PDB 5J9W) with the terminal acetyl group replaced with a 2-hydroxyisobutyryl group (from PDB 4R3U). As anticipated, the manner in which 2-hydroxyisobutyryl-CoA can bind to Esa1p is similar to that seen for the acetyl-CoA/Esa1p complex and allows a good fit of the 2-hydroxyisobutyryl group into the catalytic pocket ( Figure 1B ). Therefore, it is possible that multiple acylations, including K hib , could be catalyzed by the same enzyme.
We then carried out a series of experiments to test whether Esa1p could catalyze H4K8 hib acylation in vivo. First, we compared the levels of H4K8 hib between an ESA1 temperature-sensitive mutant esa1-531 and its wild-type counterpart. We found that H4K8 hib persisted in the mutant at permissive temperature (25 °C), despite the reduced level of modification compared to the wild type. In contrast, at the non-permissive temperature (37 °C), the modification was completely abolished ( Figure 1C ). Second, we constructed a strain carrying an amino-acid substitution (L264D) within the ER motif to diminish the enzymatic activity of Esa1p [29] . As shown in Figure  1D , H4K8 hib was dramatically decreased in this mutant. Therefore, a functional Esa1p is required for H4K8 hib . Third, we asked if Esa1p-mediated H4K8 hib requires the intact picNuA4 complex, as known for acetylation. We then performed western blot analysis in two strains: one carrying a point mutation in Epl1p, F312D, which disrupts its interaction with Esa1p; and the other with a deletion of YNG2. We found the amount of H4K8 hib was drastically decreased in both strains ( Figure 1D and 1E ). Finally, we tested if the NuA4 complex is also required for H4K8 hib by knocking out EAF1, which maintains the picNuA4 complex but disrupts NuA4 complex [30] , or EAF3, another component of the NuA4 complex. The EAF1 deletion strain showed moderate effect on H4K8 hib whereas the EAF3 deletion strain did not ( Figure 1E ). Taken together, these results indicate that the picNuA4 complex is responsible for histone H4K8 hib in S. cerevisiae.
In order to demonstrate that Esa1p catalyzes H4K8 hib directly, we performed an in vitro assay using the purified picNuA4 complex and nucleosome core particles (NCPs) [29] . The 2-hydroxyisobutyryl-CoA was synthesized chemically (Supplementary information, Figure  S1 ) and supplied as the donor. The reaction was carried out at room temperature and the production of H4K8 hib was visualized by western blot. We found that picNuA4 can efficiently catalyze 2-hydroxyisobutyrylation on H4K8 in vitro ( Figure 1F) . Together, the results of these experiments carried out both in vivo and in vitro demonstrate that Esa1p is the "writer" of H4K8 hib in yeast. Given the broad acetylation substrate spectrum of Esa1p [31] , H4K8 may serve one of the histone K hib substrate sites for Esa1p.
Tip60 has K hib transferase activity in vitro and in vivo
Given the K hib transferase activity of Esa1p in yeast, we next hypothesized that Tip60, the human homolog of Esa1p, might also be able to catalyze the K hib reaction.
To test this hypothesis, we first carried out K hib reactions in vitro using recombinant histone H4 protein and 2-hydroxyisobutyryl-CoA as substrate and cofactor, respectively. Acetyl-CoA was used as a positive control for the reactions. Western blot results showed that Tip60 could increase the global level of the histone H4K hib modification (Figure 2A) , although it had a lower intrinsic preference toward the 2-hydroxyisobutyryl-CoA (Supplementary information, Figure S2 ). Mass spectrometry analysis identified H4K8, H4K12, H4K16 and H4K31 as K hib substrates of Tip60 (Supplementary information, Figure  S3 ), indicating that Tip60 is a potential mammalian K hib transferase in vitro. To confirm this result, a Tip60-specific inhibitor, TH1834 [32] , was used to determine whether it could prevent H4 from undergoing 2-hydroxyisobutyrylation. Upon treatment of TH1834, the K hib level was significantly decreased in a similar fashion as K ac ( Figure  2B ), further suggesting that Tip60 has K hib transferase activity in vitro.
We next examined whether Tip60 regulates K hib in vivo. Knockdown of Tip60 by short interfering RNA reduced the global levels of K hib and K ac on histones, while the K hib level on a specific residue, H4K8, was decreased slightly ( Figure 2C ). In support of this observation, we found that treatment of cells with the Tip60 inhibitor, TH1834, clearly decreased H4K8 hib signals ( Figure 2D ). By contrast, overexpression of full-length Tip60 by transient transfection increased both global histone K hib and H4K8 hib levels and enhanced the K ac positive control as expected ( Figure 2E ). Quantitative mass spectrometry showed that the levels of histone H4K8 hib , H4K12 hib and H4K16 hib were increased 35%-46% in response to overexpression of Tip60, indicating that these sites are Tip60-targeted K hib substrates (Supplementary information, Figure S4 ).
Taken together, these results demonstrate that Tip60 can regulate K hib both in vitro and in vivo.
HDAC2 and HDAC3 are K hib deacylases in vitro and in vivo
HDACs, which are also called lysine deacetylases (KDACs), are a family of enzymes that can remove acetyl groups from the amine at the epsilon position of lysine side chain. Given the fact that some HDACs, such as Sirt5 and Sirt6, can also catalyze removal of other forms of lysine acylation [33] [34] [35] , we hypothesized that some HDAC member might also have enzymatic activity toward K hib . To test this possibility, we first carried out an in vitro screen of the 11 class I, II and IV deacetylases (HDAC1-HDAC11) using core histones as the substrates ( Figure 3A ). This revealed that HDAC2 and HDAC3 have the highest activity for de-2-hydroxyisobutyrylation, whereas HDAC1 only showed marginal activity in vitro. The in vitro de-2-hydroxyisobutyrylation activity of HDAC3 could be further confirmed by the inhibition of NaBu and TSA; two inhibitors for class I and II HDACs, but not NAM, an inhibitor for class III HDAC [15] . Together, these data suggested that HDAC2 and HDAC3 could remove K hib in vitro. Next, we sought to determine whether HDACs1-3 could remove K hib in vivo. Consistent with the in vitro assay, knockdown and overexpression of HDAC1 slightly affected the global level of histone K hib ( Figure 3B and 3C), while knockdown of HDAC3 or knockout of HDAC2 increased the global level of histone K hib more obviously ( Figure 3D and 3E). Compared with HDAC2 knockout, the double depletion of HDAC2 and HDAC3 led to a similar increase of the global histone K hib level. In contrast, overexpression of HDAC2 or HDAC3 reduced the global level of histone K hib ( Figure 3F ). SILAC quantification of the histone K hib dynamics indicated that the levels of K hib decreased by 30% or more after HDAC3 overexpression (Supplementary information, Table S1 ). Moreover, overexpression of both HDAC2 and HDAC3 enhanced such a decrease.
Together, these data support the conclusion that HDAC2 and HDAC3 are K hib deacylases both in vitro and in vivo.
Proteomics screening of K hib peptides in HeLa cells
To globally identify K hib substrate proteins and their modification sites, we carried out proteomic screening in HeLa cells involving peptide fractionation, affinity enrichment of K hib -peptides and HPLC-MS/MS analysis ( Figure 4A ). The specificity of the pan anti-K hib antibody used for immunoaffinity purification was verified with a dot blot assay; the antibody could only detect the peptide library bearing a fixed 2-hydroxyisobutyrylated lysine but not the peptide library bearing a fixed unmodified lysine, acetylation lysine, butyrylated lysine, crotonylated lysine or β-hydroxybutyrylated lysine (Supplementary information, Figure S5 ). The acquired raw MS data were analyzed by Maxquant software with a false discovery rate of < 1% at protein, peptide and site levels. We further removed those hits with Andromeda scores lower than 40. The experiments were performed as biological triplicates. Using this procedure, we identified 7 937 K hib sites on 1 901 proteins. To improve the reliability of the identified peptides, we eliminated 1 213 K hib sites with localization probability scores < 0.75, and eliminated redundant sites. Using these criteria, we identified 6 548 unique K hib sites on 1 725 proteins in triplicate analysis (Supplementary information, Data S1A). Of the 6 548 sites, 74% (4 867) were identified in at least two biological replicates ( Figure 4B ; Supplementary information, Data S1B), demonstrating the high reproducibility of our procedure. These K hib sites were used as high-confidence data set in subsequent analysis.
Sequence preference and subcellular localization of the K hib proteome
The identified K hib substrates have varied numbers of modification sites. We found that 617 proteins were modified at only one K hib site, while 80 proteins had more than 10 K hib sites, including Plectin (PLEC) with 58 sites and Myosin-9 (MYH9) with 44 sites ( Figure 4C ; Supplementary information, Data S1B). To determine whether there are common sequence motifs in K hib peptides, we aligned the amino-acid sequences surrounding K hib sites against all human background sequences. We found that the negatively-charged amino acids (aspartic acid and glutamic acid) were enriched at both −1 and +1 positions, whereas the positively-charged amino acid lysine was enriched at −6, −5, +5 and +6 positions ( Figure  5A ). In addition, arginine and lysine residues were under-represented at the −1 and +1 positions, respectively ( Figure 5A ). Interestingly, proline was largely depleted at most of the positions, making the sites distinct from the reported flanking sequence preference studies of K ac , lysine malonylation (K mal ) and lysine succinylation (K succ ) ( Figure 5A ) [36] [37] [38] [39] .
To explore the subcellular distribution of K hib substrates in cells, we performed a cellular compartment analysis of the K hib proteome. Recently, some PTMs, such as K mal and K succ , were reported being significantly enriched in mitochondria [37, 40] . In contrast, only ~15% of K hib proteins were annotated in mitochondria, whereas 61% and 86% of K hib proteins localized exclusively or partially in nucleus and cytosol, respectively ( Figure 5B ). This suggests that the K hib modification has a very different regulatory mechanism from K mal and K succ . In contrast to K mal and K succ , the subcellular distribution of K ac substrates is similar to that of K hib substrates. The majority of K ac substrates often reside in either the cytoplasm or the nucleus, while mitochondria account for ~5% or less of lysine-acetylated proteins [22] . Given that cytoplasmic, mitochondrial and nuclear K ac can regulate various cellular processes, the K hib pathway's major functions are likely widespread in diverse subcellular compartments.
Functional annotation of the K hib proteome
In order to explore the possible pathways affected by K hib , we performed a KEGG pathway enrichment analysis of the K hib proteins [1] . Ribosome (adjusted P = 5.65 × 10 ) pathways, were also enriched (Supplementary information, Data S2A). Moreover, our data showed that K hib proteins were enriched in energy metabolic networks, such as the citric cycle (adjusted P = 2.28 × 10 −11 ), fatty acid metabolism (adjusted P = 1.24 × 10 −5 ) and pyruvate metabolism (adjusted P = 2.08 × 10 −5 ) (Supplementary information, Data S2A). Similar to the pathway analysis, unbiased gene ontology biological process and UniProt keywords annotation of the K hib proteome showed that K hib proteins were associated with metabolic process and RNA processing (Supplementary information, Figure S6) .
We also performed a protein complex enrichment analysis of the K hib proteome with a manually curated CORUM database [41] . In accord with the pathway analysis, the top enriched protein complexes are associated with ribosome, spliceosome and proteasome (Supplementary information, Data S2B). In addition to these complexes, we identified significant enrichment of K hib in the CCT micro-complex (adjusted P = 6.09 × 10 ) and the DNA-PK-Ku-eIF2-NF90-NF45 complex (adjusted P = 6.44 × 10 −8 ) (Supplementary information, Data S2B). The TNF-α/NF-κB signal transduction pathway plays a pivotal role in various biological processes, and dysregulation of this pathway is associated with many diseases [42] . Our data showed that 9 out of 14 subunits in this complex were 2-hydroxyisobutyrylated (Supplementary information, Data S2B). The DNA-PK-Ku-eIF2-NF90-NF45 complex is involved in DNA double-strand break repair [43] . We found that 87.5% of proteins (7 out of 8) in this complex were 2-hydroxyisobutyrylated (Supplementary information, Data S2B). These results suggest that K hib can be involved in diverse cellular functions and networks that include protein synthesis and degradation, cellular signaling and DNA repair.
K hib in enzymes
Of the 346 2-hydroxyisobutyrylated enzymes, 219 enzymes have multiple K hib sites. Of these, 21 enzymes were heavily modified and had more than 10 K hib sites ( Figure 5C ; Supplementary information, Data S3). The DNA-dependent protein kinase catalytic subunit (PRK-DC), the core component of the DNA-PK-Ku-eIF2-NF90-NF45 complex, has 37 K hib sites ( Figure 5C ). Glycolysis is a catabolic process that converts glucose into pyruvate via 10 enzymatic steps [44] . Strikingly, 5 out of the 10 key enzymes required for glycolysis were heavily modified, including phosphoglycerate kinase 1 (PGK1), alpha-enolase (ENO1), pyruvate kinase isoform M2 (PKM2), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and fructose-bisphosphate aldolase A (AL-DOA) ( Figure 5C ). ENO1 is a highly-conserved enzyme that coverts 2-phosphoglycerate to the high-energy intermediate phosphoenolpyruvate. Remarkably, its activity center residue, K343, was 2-hydroxyisobutyrylated (Figure 5D) . Previous experiments showed that mutations on this site (Lys to Ala or Met) abolished enzyme activity [45] . In addition, the crystal structure of ENO1 shows that two magnesium ions are located in the active pocked within 4Å to the epsilon nitrogen atom of K343 ( Figure  5D ), and both magnesium ions are thought to participate in the catalytic reaction [45] . Therefore, the K343 hib could not only inactivate the epsilon nitrogen atom, but is also likely to occupy the space of magnesium ions, thus disrupting the interaction network of the active-site residues and hampering enzymatic activity.
In addition to these enzyme active sites, we also found that many substrates or cofactor binding sites were 2-hydroxyisobutyrylated ( Figure 5E ). For example, K186 of adenosylhomocysteinase; K147 of ALDOA; K171 of glucose-6-phosphate 1-dehydrogenase; and K147 of glutamate dehydrogenase 1 are known to be important for substrate binding (www.uniprot.com). The K745 residue of epidermal growth factor receptor (EGFR), K112 of heat shock protein HSP 90-alpha A2, K168 of endoplasmin and K220 of PGK1 are critical residues for ATP binding (www.uniprot.com). K hib on these positions is most likely to affect the protein functions by disrupting the binding interaction.
Discussion
Emerging evidence indicates that diverse newly-discovered lysine acylations are associated with normal cellular physiology and disease. Histone butyrylation, crotonylation and β-hydroxybutyrylation are associated with gene expression in diverse cellular systems [10, [46] [47] [48] . These modifications can also have specific "readers" to mediate their functions [49] [50] [51] [52] . Lysine propionylation, butyrylation, malonylation, succinylation, glutarylation all contribute to multiple heritable genetic diseases [36, 40, [53] [54] [55] . These lines of evidence suggest that lysine acylations are a family of PTMs that are physiologically relevant.
Lysine acetylation not only occurs on core histones, but also on diverse other proteins in nuclei, cytosol and mitochondria, many of which are metabolic enzymes. Previous studies have suggested that the lysine acetylation pathway has diverse functions. Given the significant structural changes associated with K hib and also its widespread abundance, its close association with gene expression, it seems that the K hib pathway is also highly likely to function similar to lysine acetylation and to have diverse regulatory roles. However, study of the K hib pathway is hindered by a lack of knowledge of its regulatory enzymes and key substrates, the major focus of this work.
Our findings on the K hib activities of Esa1p/TIP60, HDAC2 and HDAC3 broaden the enzymatic activities of the previously annotated HATs and HDACs. TIP60 is a cellular lysine acetyltransferase that is involved in the regulation of gene expression and DNA damage response. It exerts cellular functions principally through acetylation of histones and critical cellular proteins like p53, p21 and ATM kinase [56] . To our knowledge, TIP60 has not yet been found to have acyltransferase activity other than acetylation. Thus, many of the annotated acetylation-regulatory enzymes have an expanded repertoire of acyl-transferase activities, and our result provides additional complexity of enzymatic activities of these enzymes.
Our study of the comprehensive global lysine 2-hydroxyisobutyrylome has provided a data set of 6 548 reliable K hib sites on 1 725 proteins in HeLa cells. This data set represents the first K hib proteome in mammalian cell to date, and illustrates the broad landscape of the K hib pathway. Notably, 14 K hib sites were located at substrate or cofactor-binding positions, suggesting K hib on these positions may negatively regulate protein functions. Second, this study provides a valuable resource for understanding the molecular mechanism whereby K hib is associated with enzyme functions and human diseases. We detected 1 252 K hib sites on 346 enzymes in the HeLa K hib proteome (Supplementary information, Data S3) and many of these enzymes are heavily 2-hydroxyisobutyrylated, suggesting important roles of K hib in diverse cellular processes and development of disease. Third, our further analysis of the K hib proteome has shed additional light on the crosstalk between K hib and phosphorylation. We identified 115 K hib sites in the HeLa K hib proteome located within five residues of reported phosphorylation sites (Supplementary information, Data S4) by mapping the K hib proteome against the phosphorylome in UniProt database. Given that phosphorylation can serve as a functional on/off switch, these data suggest potential roles for K hib in tuning protein functions through interplay with nearby phosphorylation sites.
Our study also sheds new light on the ways that microbial metabolites might affect human health and disease. The human gut harbors trillions of microorganisms that produce multiple metabolites, which have been demonstrated to play important roles in the development of diverse diseases [8] . For example, high levels of 2-hydroxyisobutyrate in the urine of obese people have been found associated with reduced bacterial diversity in "obese" gut microbiota [12] . However, the underlying mechanisms of how the microbial metabolites affect human health and disease are poorly understood. Emerging evidence has demonstrated that fluctuations in the availability of short-chain fatty acids could directly impinge on levels of their corresponding PTMs [10, 53, 57] . In this context, given the potentially important roles of K hib in various cellular processes revealed in this study, it is highly likely that microbial metabolites, including 2-hydroxyisotutarate, play a regulatory role at the level of PTMs such as K hib in a variety of host tissues and can ultimately affect host protein functions and the overall phenotype.
Identification of key regulatory elements for the K hib pathway, including enzymes and substrate proteins, will mark a key step forward toward description of this pathway. It is expected that histone K hib pathway will have unique binding modules in a similar fashion to histone lysine acetylation and crotonylation [49, 50] . It seems highly likely that the relative abundance of histone K ac and K hib in a given substrate protein such as a histone protein is regulated by metabolic status and concentrations of acyl-CoAs in a similar fashion as histone lysine crotonylation [10] . We now require functional studies of these enzymes and substrates, together with the discovery and characterization of their binding proteins (or "readers"), and investigations of the governing principles that acyl-CoA metabolism might have on these proteins. Such future studies will greatly enhance our understanding of the K hib pathway and molecular regulation of cellular functions mediated by its cognate short-chain fatty acid.
Materials and Methods
Plasmids, siRNA, antibodies and cell lines
Tip60 was cloned into pcDNA3.0 with a Flag tag. The construction was verified by DNA sequencing. siRNA was purchased from Dharmacon (L-006301-00-0005). The antibodies used here were anti-Pan K ac (PTM Biolabs, PTM-101), anti-Pan K hib (PTM Biolabs, PTM-801), anti-H4K8 ac (PTM Biolabs, PTM-120), anti-H4K8 hib (PTM Biolabs, PTM-805), anti-H4 (Abcam, ab31830), anti-Flag (Sigma-Aldrich, F7425), anti-Tubulin (Abcam, ab6160) and anti-Tip60 (Abcam, 23886). Cell lines were purchased from ATCC (www.atcc.org) and used without further authentication, including HEK293 (ATCC CRL-1573), HEK293T (ATCC CRL-3216), HeLa (ATCC CCL-2) and U2OS (ATCC HTB-96). No mycoplasma contamination was detected using a MycoAlert Mycoplasma Detection Kit (Lonza, LT07-118).
Stable isotope labeling of cells and transfections
HEK293T cells were grown in lysine-free DMEM supplemented with 10% dialyzed FBS, and either light ( 12 C 6 14 N 2 -l-Lysine) or heavy ( 13 C 6 14 N 2 -l-Lysine) lysine (100 mg/L). Cells were grown for more than seven generations to achieve more than 98% labeling efficiency. For the transfections, HeLa and HEK293 cells were cultured in DMEM medium supplemented with 10% FBS, 50 U/ mL penicillin and 50 mg/mL streptomycin in a 5% CO 2 atmosphere at 37 °C. Transfection to achieve transient overexpression was 
Depletion of HDAC1, HDAC2 and HDAC3
Two pools of HEK293T cells were transfected twice with HDAC1 siRNA (Genepharma, siHDAC1: (#1) 5′-GCUC-CUCUGACAAACGAAUTT-3′; (#2) 5′-CCGGUCAUGUC-CAAAGUAATT-3′; (#3) 5′-GCUGUACAUUGACAUUGAUTT-3′) and a negative control siRNA (Genepharma, 5′-UUCUCCGAAC-GUGUCACGUTT-3′), respectively. About 48 h after the second transfection, the cell lysates were probed with anti-K ac and anti-K hib SPRINGER NATURE | Cell Research | www.nature.com/cr antibodies.
HEK293T cells were transfected with an empty vector PX458 and an HDAC2 knockout vector PX458-sgRNA (HDAC2), respectively, to get two stable cell lines. Depletion of HDAC2 and HDAC3 was further achieved by using the HDAC2 knockout HEK293T cell line transfected twice with a siRNA mix against HDAC3 (Genepharma, siHDAC3: (#1) 5′-CCGCCAGACAAUC-UUUGAATT-3′; (#2) 5′-GAGCUUCCCUAUAGUGAAUTT-3′; (#3) 5′-GGGAAUGCGUUGAAUAUGUTT-3′). The HDAC2 knockout HEK293T cells transfected twice with siRNA (Genepharma, 5′-UUCUCCGAACGUGUCACGUTT-3′) were used as negative control. About 48 h after the last transfection, the K hib and K ac levels were assessed by western blot using extractions of whole-cell lysates.
Preparation of cell lysate
Cells were sonicated for 3 min on ice using a high-intensity ultrasonic processor (Scientz) in lysis buffer (8 M urea, 2 mM EDTA, 3 µM TSA, 50 mM NAM, 5 mM DTT and 1% Protease Inhibitor Cocktail III). The remaining debris was removed by centrifugation at 18 000× g at 4 o C for 3 min. The protein concentration was determined using a 2-D Quant kit according to the manufacturer's instructions.
Trypsin digestion of cell lysate
Proteins in the cell lysate were reduced with 10 mM DTT for 1 h at 37 o C, alkylated with 20 mM iodoacetamide for 45 min at room temperature in darkness, and the excess iodoacetamide was blocked by 20 mM cysteine. Then the protein sample was diluted by adding 100 mM NH 4 HCO 3 to reduce the urea concentration to < 2 M. Trypsin was added at 1:50 trypsin-to-protein mass ratio for the first digestion overnight and 1:100 trypsin-to-protein mass ratio for a second 4 h-digestion. Finally, 18 mg of proteins from the HeLa cells lysate was digested for subsequent experiments.
Peptide fractionation with high-pH reverse-phase chromatography
The peptides from HeLa cells lysate were then divided into three equal parts, and each of them (6 mg) was fractionated into six fractions by high pH reverse-phase HPLC using an Agilent 300 Extend C18 column (5 µm particles, 4.6 mm ID, 250 mm length). Briefly, peptides were first separated using a gradient of 2%-60% acetonitrile in 10 mM ammonium bicarbonate at pH 10 over 90 min into 90 fractions. The peptides were then combined into six fractions and dried by vacuum centrifugation.
Immunoaffinity enrichment
To enrich K hib peptides, total peptides dissolved in NETN buffer (100 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl, 0.5% NP-40, pH 8.0) were incubated with pre-washed pan anti-K hib beads (PTM Biolabs Inc., Chicago, IL) at 4 o C overnight with gentle shaking. The beads were washed four times with NETN buffer and twice with ddH 2 O. The bound peptides were eluted from the beads with 0.1% trifluoroacetic acid, and the eluted fractions were combined and vacuum-dried.
Mass spectrometry
Samples were dissolved in 0.1% formic acid and loaded onto a reversed-phase pre-column (Acclaim PepMap 100, Thermo Scientific). Peptide separation was performed using a reversed-phase analytical column (Acclaim PepMap RSLC, Thermo Scientific) with a gradient of 5-80% HPLC buffer B (0.1% formic acid in 90% acetonitrile, v/v) in buffer A (0.1% formic acid in water, v/v) at a flow rate of 300 nl/min over 60 min on an EASY-nLC 1000 UPLC system. The samples were analyzed by Q Exactive Plus Mass Spectrometers (ThermoFisher Scientific). A data-dependent procedure that alternated between one full mass scan followed by the top 20 most intense precursor ions was applied with 30 s dynamic exclusion. Intact peptides were detected with a resolution of 70 000 at 200 m/z, and ion fragments were detected with a resolution of 17 500 at 28% normalized collision energy.
Database search and data filter criteria
The resulting MS/MS data were processed using MaxQuant with integrated Andromeda search engine (v.1.3.0.5) [58] . Tandem mass spectra were searched against the UniProt Human protein database (88 277 entries, http://www.uniprot.org) concatenated with reverse decoy database. Trypsin/P was specified as cleavage enzyme allowing up to two missing cleavages and five modifications per peptide. Carbamidomethylation on cysteine was specified as fixed modification. Oxidation on methionine, 2-hydroxyisobutyrylation on lysine, acetylation on lysine and acetylation on protein N-terminus were specified as variable modifications. False discovery rate thresholds for protein, peptide and modification site were specified at 1%. Minimum peptide length was set at 7. All the other parameters in MaxQuant were set to default values. K hib identified on peptides from reverse or contaminant protein sequences, peptides with an Andromeda score below 40, site localization probability below 0.75 and redundant K hib sites were removed. In addition, K hib sites on the peptide C-terminus were eliminated, unless the peptide C-terminus was also the corresponding protein C-terminus. For the SILAC sample data, K hib site ratios were normalized by the quantified protein expression levels.
In vitro acetylation and 2-hydroxyisobutyrylation assay
Recombinant human Tip60 and Histone H4 proteins were purchased from Cayman (10783) and NEB (M2504S), respectively. For each reaction, 250 ng of Tip60 protein, 2.5 µg of H4 protein and 10 µM of CoA were added in reaction buffer (50 mM Tris-CI, pH 8.0, 10% glycerol, 10 mM butyric acid, 0.1 mM EDTA, 1 mM DTT and 1 mM PMSF). The reaction mixtures were incubated at 30 o C for 1 h, followed by addition of SDS sample buffer. The levels of acetylation and 2-hydroxyisobutyrylation were assessed by western blot.
PicNuA4 in vitro assay
The NCP with 147 bp 601 "wisdom" sequence was prepared using luger's protocol. PicNuA4 complex was prepared using an unpublished method. The reaction system was 1 µM NCP, 0.01 µM picNuA4, 50 µM 2-hib-CoA, 50 mM NaCl, 10 mM HEPES (pH 7.0), 0.1 mg/mL BSA. The assay was performed at room temperature, utilizing picNuA4 to start the reactions with a time-based gradient. SDS-loading buffer was used to stop the reactions with incubation at 100 °C for 1 min. The signal was detected by western blot.
Protein function annotation analysis
Enrichment analysis for KEGG pathway and PFAM domain was performed using a hypergeometric test in GOstats package in R [59] . Protein complexes were enriched basing on that manually curated CORUM protein complex database [41] for all mammals using a hypergeometric test. Unbiased gene ontology terms and UniProt keywords enrichment analyses were performed using a web tool (https://agotool.sund.ku.dk) [60] .
Protein-protein interaction network analysis
The STRING database (v10, http://www.string-db.org/) was used for analyzing the protein-protein interaction network of the Tip60-regulated K hib proteome. Interactions with the highest confidence score (above 0.9) were selected and the network was visualized in Cytoscape (v.3.2.1).
Correlation between K hib and mutation/phosphorylation
In-house developed scripts were applied to map K hib to known mutations and phosphorylation sites. Disease-related mutations were extracted from UniProt (http://www.uniprot.org) and COS-MIC (Catalogue of Somatic Mutations in Cancer, http://cancer. sanger.ac.uk/cosmic) databases. Protein dysfunction-related mutations, substrate/cofactor-binding sites and reported phosphorylation sites were extracted from UniProt database.
Chemical synthesis of 2-hydroxyisobutyryl-CoA
The method used to synthesize 2-hydroxyisobutyryl-CoA was modified from a previous study [61] . About 0.88 g (10 mmol) 2-hydroxyisobutyric acid and 1 mL thiophenol were dissolved in 50 mL pre-cooled dimethylformamide (DMF), to which 2.52 g (12.2 mmol) dicyclohexylcarbodiimide in 50 mL DMF was added drop by drop and the mixture was stirred for 3 h on ice bath. About 40 mL of cold water was then added and the solution was filtered. The filtrate was extracted with 100 mL of ether and the organic layer was washed three times with saturated NaCl. The ether extract was dried using anhydrous sodium sulfate and ether evaporated. The residue was then purified by silica gel column chromatography with an elution solvent consisting of ethylacetate:hexane (20:1). The roughly purified product was further purified by silica thin-layer chromatography with an elution solvent consisting of ethylacetate:hexane (1:4). The target band was collected and the purified S-phenyl 2-hydroxy-2-methylpropanethioate was used as the reactant for the next step. 16 mg of S-phenyl 2-hydroxy-2-methylpropanethioate was dissolved in 500 µL 0.1 M NaHCO 3 (pH 8.0) and 200 µL dioxane mixture was added to a solution of 10 mg sodium salt of CoA dissolved in 1 mL NaHCO 3 (pH 8.0) at 0 °C. The mixture was reacted overnight, and then was neutralized by adding 1 N HCl to pH 7.0 to stop the reaction. About 8 mL ether was used to extract the unreacted reactant and this step was repeated five times. Then 8 mL of ethylacetate was used to extract the water phase and this step was repeated eight times. The final product remained in the water phase. Water was allowed to evaporate at 30 °C in order to achieve the solid end product.
Data availability
The mass spectrometry proteomics data have been deposited in the ProteomeXchange Consortium via the PRIDE [62] partner repository with the data set identifier PXD005414.
